Capsida Biotherapeutics Opens New Facility In Thousand Oaks
socalTECH
JULY 23, 2021
Thousand Oaks-based biotech company Capsida Biotherapeutics says it has opened up a new, 15,000 square-foot facility in Thousand Oaks for its gene therapy manufacturing efforts. The company is developing targeted adeno-associated virus (AAV) gene therapies for patients with debilitating and life-threatening genetic disorders. The company says that building its own manufacturing facility will help it eliminate dependence on ontract manufacturing.
Let's personalize your content